Earlybird Health, a division of VC firm Earlybird Venture Capital, has completed the final close of its £148m fund. The fund is aimed at European startups in the healthcare sector, with a focus on digital health, diagnostics, medical devices, research and development tools, and biopharma. Earlybird Venture Capital, based in Germany with a presence in London, has previously supported several British startups, including Sikoia, Sense, and Snyk. The latest close included a £17.6m commitment from Sheffield-based investor British Patient Capital, which described the UK as a “global centre for healthcare innovation”.
Earlybird Health successfully raises £148m fund in final close
Latest from Blog
Synthara Secures $11M in Funding for Future Growth
“`html TLDR: Synthara, a semiconductor provider based in Zurich, Switzerland, raised over USD 11M in funding led by Vsquared Ventures. The company will use the funds to introduce its product, ComputeRAM, for
IDG Blockchain joins seed round for U2U Network’s DePIN technology
TLDR: IDG Blockchain co-leads seed round investment into U2U Network to advance DePIN technology DePIN technology aims to revolutionize the decentralized physical infrastructure networks Summary: In a strategic move to promote the
Dodona Analytics Secures Series A Investment
TLDR: Dodona Analytics, a London-based provider of an eMobility platform for EV charging networks, raised Series A funding led by Flashpoint Venture Capital. The company plans to use the funds to accelerate
Ovation raises $9M in Series A funding for growth
TLDR: – Ovation, a provider of a guest experience platform for multi-unit restaurants, secured an undisclosed amount of Series A funding, bringing their total raised amount to $9M. – The funding round
Revolutionizing Climate Solutions: MIT Fund Tackles Toughest Environmental Challenges
TLDR: The Engine Ventures, backed by MIT, raised $400M to support tough tech companies focusing on decarbonizing heavy industries. Heavy industries are major climate polluters, emitting over a fifth of human-caused CO2